/Investor DB

Empath Ventures — Full Portfolio

28 tracked investments · listed companies and verified rows first

Coherence Neurocoherenceneuro.comin𝕏

Coherence develops neurotechnology systems that measure and modulate brain activity to treat cancer and other neurological diseases.

AI & Machine LearningBiotechMedical DevicesSan Francisco, US

Ben Woodington(Co-founder & CEO)inElise Jenkins(Co-founder & CTO)in

Co-investorsArtesianASDF VenturesBlackbird VenturesDivergent CapitalIrregular ExpressionsPossible Ventures+5 more

Focalpointlpfocalpointlp.comin𝕏

The page references health, wellbeing and performance under the banner "Human 3," alongside expertise in AI/ML, medicinal chemistry/pharmacology, and aging-brain research.

AI & Machine LearningLongevityWellness & FitnessSan Francisco, US

Co-investorsXEIA Venture Partners

Freedom Biosciencesfreedombio.coin𝕏

Freedom Biosciences develops neuropsychiatric therapeutics, focusing on novel treatments for conditions including depression, PTSD, and alcoholism.

BiotechDigital HealthMental Health

Dr. John Krystal(Co-founder & CEO)inDina Burkitbayeva(Co-founder)in

Co-investorsBeni Venture CapitalEvolution VC PartnersGaingelsIter InvestmentsLongeVCManta Ray Ventures+3 more

Mindstate Design Labsmindstate.designin𝕏Seed · Nov 2024

Mindstate Design Labs is a clinical-stage drug development company that uses AI to map the biological basis of emotion and cognition, synthesizing psychedelic phenomenology and biochemical data to design pharmaceutical compounds that induce specific therapeutic emotional and cognitive states for mental health treatment.

AI & Machine LearningBiotechHealthtechMental HealthSan Francisco, US

Dillan DiNardo(CEO)inTom Ray(Founder)inTegan Johnson(Director of Operations)

BoardRand Hindi(Director)in

Co-investorsARA NEA Ventures (Brand: Dmz.Xyz)Blast.ClubGaingelsImmeasurableInitialized CapitalMetaplanet+14 more

Motif Neurotechmotifneuro.techin𝕏Jan 2024

Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression.

BiotechDeep TechDigital HealthHealthtechMedical DevicesHouston, US

Sameer Sheth(Founder)inSunil Sheth(Founder)Nick Halper(Chief Operating Officer)inSteve Goetz(Chief Technology Officer)inAnthony Arnold(Director)inKaiyuan Yang(Founder)

Co-investorsArboretum VenturesDivergent CapitalDolby Family VenturesFeatures Capital HoldingsPsyMed VenturesTMC Venture Fund+6 more

NeuroBionicsneurobionics.ioinNov 2025

NeuroBionics develops soft, flexible neural interface technologies for neuromodulation applications.

BiotechDeep TechHealthtechMedical DevicesSomerville, US

MJ Antonini(Founder, CEO)inNicki Driscoll(Founder, CTO)Polina Anikeeva(Founder)inNicolette Driscoll(Founder)in

Co-investorsDevice of Tomorrow CapitalDolby Family VenturesFuture VenturesGreyMatterMana VenturesPioneer+4 more

Superpowersuperpower.comin𝕏

Superpower offers personalized health testing and monitoring for consumers, analyzing 100+ biomarkers across multiple body systems.

AI & Machine LearningDigital HealthWellness & Fitness

Jacob Peters(Founder)inDr Anant VinjamooriKevin Unkrich(Founder)inMax Marchione(Founder)in

Co-investorsAirTree VenturesAOKI LABSARA NEA Ventures (Brand: Dmz.Xyz)AurumBackwards CapitalBlack Flag+21 more

TARA Mindtaramind.comOct 2023

TARA Mind offers a specialized, clinician-guided mental health benefit that employers add to their existing benefits to serve workers with treatment-resistant conditions, connecting them to a vetted U.S. network of therapists and physicians for evidence-based care.

Digital HealthHR TechMental HealthMclean, US

Marcus Capone(Founder & CEO)inBrian Dolan(Executive Officer)Barrett Yates Mack(Executive Officer)Heather Stevenson(Executive Officer, Director)

Co-investorsRed Cell IncubationXEIA Venture PartnersPrime Movers Lab

TippingPoint Biosciencestippingpointbiosciences.comin

TippingPoint Biosciences is a therapeutics company developing a drug discovery platform that targets unstructured regions in chromatin proteins to treat diseases caused by dysfunctional genome chromatin packaging, with a focus on cancer.

BiotechDeep TechHealthtechSan Francisco, US

Laura Hsieh(Founder & CEO)in

Co-investorsFREEFLOWSOSVBrightEdgeSazzeStoryHouseXEIA Venture Partners

Ultra Bionicsultra-bionics.com

Ultra Bionics develops implantable focused ultrasound technology placed inside the skull to deliver targeted, adaptive neuromodulation for treating neurological diseases, beginning with Parkinson's disease.

Deep TechHealthtechMedical DevicesMelbourne, AU

Co-investorsXEIA Venture Partners

Wavepathswavepaths.comin𝕏Nov 2021

Wavepaths develops adaptive therapeutic music designed to support mental health and wellness practitioners in their sessions.

Digital HealthMental HealthWellness & Fitness

Mendel Kaelen(Founder & CEO)in

Co-investorsMITONReflex CapitalTabula Rasa VenturesLIONHEART VENTURESNeo Kuma VenturesPalo Santo VC

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

ApertureBeondBiosphereForecast BioFreedomKadenceKerna LabsLykosMotifPangeaPodcastPreclinicalSynchronTippingPointVonovaWonderXylo

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.